McKesson Corp. (MCK) News

McKesson Corp. (MCK): $532.00

4.68 (+0.89%)

POWR Rating

Component Grades

Momentum

C

Stability

B

Sentiment

Quality

C

Add MCK to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#6 of 66

in industry

Filter MCK News Items

MCK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MCK News Highlights

  • For MCK, its 30 day story count is now at 10.
  • Over the past 17 days, the trend for MCK's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • TOP and DRUG are the most mentioned tickers in articles about MCK.

Latest MCK News From Around the Web

Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Faizan Farooque on InvestorPlace | December 27, 2023

McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference

IRVING, Texas, December 27, 2023--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.

Yahoo | December 27, 2023

McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.

Yahoo | December 26, 2023

McKesson's (NYSE:MCK) five-year earnings growth trails the 34% YoY shareholder returns

For many, the main point of investing in the stock market is to achieve spectacular returns. And we've seen some truly...

Yahoo | December 23, 2023

Why McKesson (MCK) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Yahoo | December 22, 2023

Institutional investors in McKesson Corporation (NYSE:MCK) lost 3.1% last week but have reaped the benefits of longer-term growth

Key Insights Institutions' substantial holdings in McKesson implies that they have significant influence over the...

Yahoo | December 19, 2023

13 Most Profitable Pharmaceutical Stocks Now

In this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device […]

Yahoo | December 18, 2023

Top 30 Largest US Companies by 2023 Revenue

In this article, we will be covering the top 30 largest US companies by 2023 revenue. If you want to skip our detailed analysis, you can go directly to the Top 5 Largest US Companies by 2023 Revenue. The United States is home to some of the most valuable companies in the world. The US […]

Yahoo | December 14, 2023

Here's Why You Should Retain McKesson (MCK) Stock for Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Yahoo | December 13, 2023

McKesson (MCK) Announces Availability of FDA-Approved Drug

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for desmoid tumors.

Yahoo | December 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!